One under-$10 stock that's worth keeping an eye on is medical products and device maker for regenerative medicine Cytori Therapeutics (CYTX). This stock has been hammered by the sellers in 2011, with shares off by over 43%.
If you take a look at the chart for Cytori, you'll notice that this stock has been downtrending from its July high of $5.72 to its recent low of $2.32 a share. After hitting that low, the stock has rebounded and started to print higher lows, which could be signaling a bullish trend change. As long as this stock continues to make higher lows, then traders should watch CYTX for a breakout in the near-term.
Market players should look for a breakout to trigger if CYTX can clear and close above its 50-day moving average of $3.10 a share on solid volume. Look for volume that's tracking in close to or above its three-month average action of 432,400 shares. If the stock can close over its 50-day convincingly, then watch for a bigger breakout to trigger once it moves above $3.30 to $3.50 with volume.One could be a buyer of this stock once it clears the 50-day with volume. If we get that move, I would then add to any long position once the stock takes out $3.30 a share with volume. Target a run back towards 4.50 a share, or possibly much higher if the bulls gain full control of this stock. Keep in mind that this is a heavily shorted name since the current short interest as a percentage of the float for CYTX is 18%. Any near-term breakout could trigger a monster short-squeeze, so make sure to watch for any high volume spikes above that 50-day in the coming days or weeks. >>10 Most Shorted Stocks in Biotech
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV